The FDA can still choose to give MNKD an CRL despite today's positive vote. There is still risk in MNKD.
Hence the gains will be somewhat more limited than most people think.
My guess is MNKD opens at $9 a share then trades down to about $8 a share.
Still a big win for longs. But, MNKD won't go above $10 until they get FDA approval instead of the dreaded CRL delay
you're either an idiot or a trapped short.....it's a slam-dunk for approval.
Sentiment: Strong Buy
with a 14-0 vote for type 2, and 13-1 for type 1,... It's just as good as approved by FDA